Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalyzed Carboxylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109651202B reveals a safe iridium-catalyzed route using dimethyl sulfoxide ylide and CO2, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.